These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

437 related items for PubMed ID: 20727143

  • 1. Surveillance of pyrazinamide susceptibility among multidrug-resistant Mycobacterium tuberculosis isolates from Siriraj Hospital, Thailand.
    Jonmalung J, Prammananan T, Leechawengwongs M, Chaiprasert A.
    BMC Microbiol; 2010 Aug 20; 10():223. PubMed ID: 20727143
    [Abstract] [Full Text] [Related]

  • 2. Direct Detection of Pyrazinamide Resistance in Mycobacterium tuberculosis by Use of pncA PCR Sequencing.
    Tam KK, Leung KS, Siu GK, Chang KC, Wong SS, Ho PL, Leung EK, Yam WC.
    J Clin Microbiol; 2019 Aug 20; 57(8):. PubMed ID: 31189582
    [Abstract] [Full Text] [Related]

  • 3. Pyrazinamide Susceptibility and pncA Mutation Profiles of Mycobacterium tuberculosis among Multidrug-Resistant Tuberculosis Patients in Bangladesh.
    Rahman A, Ferdous SS, Ahmed S, Rahman SMM, Uddin MKM, Pholwat S, Gratz J, Houpt E, Banu S.
    Antimicrob Agents Chemother; 2017 Sep 20; 61(9):. PubMed ID: 28630193
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pyrazinamide resistance and mutations in pncA among isolates of Mycobacterium tuberculosis from Khyber Pakhtunkhwa, Pakistan.
    Khan MT, Malik SI, Ali S, Masood N, Nadeem T, Khan AS, Afzal MT.
    BMC Infect Dis; 2019 Feb 06; 19(1):116. PubMed ID: 30728001
    [Abstract] [Full Text] [Related]

  • 6. Prevalence and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Southern China.
    Pang Y, Zhu D, Zheng H, Shen J, Hu Y, Liu J, Zhao Y.
    BMC Infect Dis; 2017 Nov 06; 17(1):711. PubMed ID: 29110640
    [Abstract] [Full Text] [Related]

  • 7. Genotypic characterization of pyrazinamide resistance in Mycobacterium tuberculosis isolated from Lusaka, Zambia.
    Bwalya P, Yamaguchi T, Mulundu G, Nakajima C, Mbulo G, Solo ES, Fukushima Y, Kasakwa K, Suzuki Y.
    Tuberculosis (Edinb); 2018 Mar 06; 109():117-122. PubMed ID: 29559115
    [Abstract] [Full Text] [Related]

  • 8. Resistance to pyrazinamide in Russian Mycobacterium tuberculosis isolates: pncA sequencing versus Bactec MGIT 960.
    Maslov DA, Zaĭchikova MV, Chernousova LN, Shur KV, Bekker OB, Smirnova TG, Larionova EE, Andreevskaya SN, Zhang Y, Danilenko VN.
    Tuberculosis (Edinb); 2015 Sep 06; 95(5):608-12. PubMed ID: 26071666
    [Abstract] [Full Text] [Related]

  • 9. Phenotypic and genotypic characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis clinical isolates in Hangzhou, China.
    Liu W, Chen J, Shen Y, Jin J, Wu J, Sun F, Wu Y, Xie L, Zhang Y, Zhang W.
    Clin Microbiol Infect; 2018 Sep 06; 24(9):1016.e1-1016.e5. PubMed ID: 29288021
    [Abstract] [Full Text] [Related]

  • 10. [Characteristics of pncA gene in multidrug-resistant Mycobacterium tuberculosis isolates and its correlation with drug resistance to pyrazinamide].
    Hong CY, Wang F, Gui J, Liu XL.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2012 May 06; 46(5):436-9. PubMed ID: 22883731
    [Abstract] [Full Text] [Related]

  • 11. Pyrazinamide resistance-conferring mutations in pncA and the transmission of multidrug resistant TB in Georgia.
    Sengstake S, Bergval IL, Schuitema AR, de Beer JL, Phelan J, de Zwaan R, Clark TG, van Soolingen D, Anthony RM.
    BMC Infect Dis; 2017 Jul 12; 17(1):491. PubMed ID: 28697808
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of phenotypic and genotypic methods for pyrazinamide susceptibility testing.
    Shenai S, Rodrigues C, Sadani M, Sukhadia N, Mehta A.
    Indian J Tuberc; 2009 Apr 12; 56(2):82-90. PubMed ID: 19810590
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Estimation of pyrazinamidase activity using a cell-free In vitro synthesis of pnca and its association with pyrazinamide susceptibility in Mycobacterium tuberculosis.
    Rueda D, Bernard C, Gandy L, Capton E, Boudjelloul R, Brossier F, Veziris N, Zimic M, Sougakoff W.
    Int J Mycobacteriol; 2018 Apr 12; 7(1):16-25. PubMed ID: 29516881
    [Abstract] [Full Text] [Related]

  • 19. Pyrazinamide susceptibility testing of Mycobacterium tuberculosis by high resolution melt analysis.
    Pholwat S, Stroup S, Gratz J, Trangan V, Foongladda S, Kumburu H, Juma SP, Kibiki G, Houpt E.
    Tuberculosis (Edinb); 2014 Jan 12; 94(1):20-5. PubMed ID: 24246607
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.